超碰97人人爱人人做-超碰97人人操-超碰97人人操人人干-超碰97人人操人人摸-超碰97人人艹-超碰97人人干人人爱

Gene Therapy
The Gene Editing Technology Innovation Platform
Hematopoietic Stem Cell Platform

Gene Editing Technology Innovation Platform

Gene Editing Technology Innovation Platform

The Gene Editing Technology Innovation Platform (CRISTARS®) is dedicated to developing international leading gene editing tools, obtaining core technologies with independent intellectual property rights, and paving the important foundation for gene editing technology translation. The platform is based on the combination of different single-stranded DNA deaminase structural domains and Cas9 nickase to develop a new generation of DNA base editing tools for broader and more accurate gene editing. The platform has successfully created the world-leading dual base editor and the ultra-high activity cytidine single-base editor (hyper CBE, HyCBE), which can efficiently convert two bases, improve editing activity and broaden the target range. The research results have been published in high-impact peer-review journals such as Nature Biotechnology, Nature Cell Biology, and Cell Research.

World's first successful application of CRISPR/Cas9 for mammalian gene editing

Gene editing is a technology to modify genes with precise modifications, which can be achieved with high efficiency and specificity for specific genomic DNA (or RNA), just as freely and accurately as editing text. In August 2013, a team of Bioraylab scientists published in the prestigious international journal Nature Biotechnology (IF≈43.11) the description of The CRISPR/Cas9 system was successfully used to edit genes in mice and rats. In the years since, Bioraylab scientists have continued to improve the gene editing system, applying it to a variety of applications including gene therapy, cell therapy and humanized animals.

The development of the era of gene therapy

In 2023, the world's first all human targeted BCMA CAR-T therapy "FUCASO" (Equecabtagene Autoleucel) was approved for sale in China for the treatment of recurrent or refractory multiple myeloma (R/R MM)
In 2022, Cilta cel, the first CAR-T cell therapy for the treatment of r/r MM in China, was approved by the FDA for marketing
In 2021, China's first CAR-T product, Aquilensai injection, was approved for marketing by the Chinese NMPA for post-treatment relapsed or refractory diffuse large B-cell lymphoma (DLBCL)
In 2020，CRISPR/Cas9 gene editing technology wins Nobel Prize in Chemistry
In June 2019, zynteglo, the world's first gene therapy drug ,was approved for marketing by the EU EMA for the treatment of thalassemia
In May 2019, Zolgensma, the world's first gene therapy drug,was approved for marketing by the FDA for the treatment of SMA
In 2018, the first CRISPR/Cas9-based in vivo gene therapy clinical trial (EDIT-101) was approved by the FDA for the treatment of Leber Congenital Amaurosis Type 10 (LCA)
In 2017, Kymriah, the world's first CAR-T product, received FDA approval to market for the treatment of relapsed or refractory acute lymphoblastic leukemia (ALL)
In 2016, the first generation of single-base editors were developed
In November 2013, the third generation gene editing technology CRISPR/Cas9 (clustered regularly spaced short palindromic repeats) was introduced
In 2012, Glybera, the world's first AAV gene therapy drug, was approved for marketing by the EU EMA for the treatment of lipoprotein lipase deficiency (LPLD)
In 2010, TALENs (transcription activation-like effector nucleases), a second-generation gene editing technology, was introduced
In 2003, Gendicine, the world's first gene therapy drug, was approved for marketing by the NMPA in China for the treatment of head and neck squamous cell carcinoma (HNSCC)
In 2001, the first generation of gene editing technology ZFNs (zinc finger nucleases) was introduced
In 1990, the world's first clinical trial of gene therapy was approved by the FDA for the treatment of adenosine deaminase deficiency (ADA-SCID)
Back to top
主站蜘蛛池模板： 免费国产v片手机视 | 欧美传媒影 | 国产在线观看精品日韩 | 97在线视频观看在线观看视频 | 精品三级影视亚洲 | 欧美搡bb| 日韩亚洲欧美三区中文字幕 | 电影推荐 | aaa亚洲男人的天堂 国产丝袜大片 | 国产片台湾在线观看免费 | 99re6在线观看国产 | 欧美日韩国产一区二区三 | 三年片在线观看免费大全电影 | 7799天天综合 | 亚洲国产丝袜美腿在线播放 | 国产人成中文字幕 | 中文字幕三级 | 偷拍精品视频一区二区三区 | 欧洲精品不卡1卡2卡三卡 | 亚洲十欧美十 | 区二区视频在线观看 | 欧美综合网| 国产精品1000部在线观看 | 免费高清影院在线观看 | 亚洲日本在线播放视频 | 愛妃精選)国产视频二区 | 国产精品露脸国语对白 | 区视频在线观看 | 国产又粗又猛又黄又爽的视频 | 国产免费aⅴ一区二区三区 禁止18点击进 | 欧美日韩美女精品一区二区 | 全部免费的电视剧大全 | 九热视频 | 国产性感精品 | 亚洲综合国产一区在线 | 国语自产精品 | 精品午夜一级一二三区 | 免费变态视频网站网址不卡 | 亚洲欧美日韩国产精品专区网 | 国产在线成人 | 国产999精 |